Generative AI Patient Education Module for Breast Oncology

Recruiting now · Not applicable

Conditions studied: Breast Cancer, Metastatic Breast Cancer, Carcinoma of the Breast

In brief

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.

Key facts

Study ID

NCT07512271

Run by

University of California, San Francisco

People needed

35

Starts

2026-07-14

Expected to finish

2027-01-31

Last updated by the study team

2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Females or males ages 18 and over.
• Patients must have either:
• Stage IV breast cancer facing a treatment change and are expected to have follow-up visits at least once every three months, or
• Stage I-III breast cancer diagnosed within the past 6 months.
• Basic computer literacy and regular internet access at home.
• Able to understand study procedures and to comply with them for the entire length of the study.
• Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.

You may not qualify if…

• Contraindication to any study-related procedure or assessment.
• Cognitive impairment that would interfere with tool usage or survey completion

Where it is running

• University of California, San Francisco — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.